These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6173622)

  • 1. Differentiation of types of interferon by kinetics of development of the antiviral state.
    Dianzani F; Baron S
    Methods Enzymol; 1981; 78(Pt A):409-14. PubMed ID: 6173622
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune interferon activates cells more slowly than does virus-induced interferon.
    Dianzani F; Salter L; Fleischmann WR; Zucca M
    Proc Soc Exp Biol Med; 1978 Oct; 159(1):94-7. PubMed ID: 714938
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation by interferon of the events leading to the antiviral state.
    Dianzani F; Baron S
    Tex Rep Biol Med; 1977; 35():297-306. PubMed ID: 358457
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth-inhibitory and antiviral activity of purified leukocyte interferon.
    Evinger M; Rubinstein M; Pestka S
    Ann N Y Acad Sci; 1980; 350():399-404. PubMed ID: 6165289
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.
    Rubin BY; Gupta SL
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5928-32. PubMed ID: 6160587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming of interferon action.
    Fleischmann WR
    Tex Rep Biol Med; 1977; 35():316-25. PubMed ID: 616670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferon. (Obtaining, purification and experimental-clinical study of interferon in the USSR)].
    Furer NM; Pokidova NV; Ermol'eva ZV
    Antibiotiki; 1967 Nov; 12(11):1027-33. PubMed ID: 4875264
    [No Abstract]   [Full Text] [Related]  

  • 9. A micro assay for mouse and human interferon. II. Dose-response in different in cell-virus systems.
    Dahl H
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Jun; 81(3):359-64. PubMed ID: 4360138
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral and anticellular activities of human and murine type I and type II interferons in human cells monosomic, disomic, and trisomic for chromosome 21.
    Zhang ZX; De Clercq E; Heremans H; Verhaegen-Lewalle M; Content J
    Proc Soc Exp Biol Med; 1982 May; 170(1):103-11. PubMed ID: 6177006
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of ovine and caprine cells to measure antiviral effects of interferon.
    Yilma T
    Methods Enzymol; 1986; 119():551-8. PubMed ID: 2429156
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon standards: a memorandum.
    J Biol Stand; 1979; 7(4):383-95. PubMed ID: 536379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective antiviral assay of the interferons by computer assisted data collection and analysis.
    Forti RL; Schuffman SS; Davies HA; Mitchell WM
    Methods Enzymol; 1986; 119():533-40. PubMed ID: 2429154
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological properties of natural and recombinant interferons.
    Pestka S; Evinger M; Maeda S; Rehberg E; Familletti PC; Kelder B
    Tex Rep Biol Med; 1981-1982; 41():31-6. PubMed ID: 6184819
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon assay anomaly variation of interferon response with cell type and sialic acid content.
    Schwartz AA; Villani-Price D
    Adv Exp Med Biol; 1978; 110():153-7. PubMed ID: 727039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mx GTPase family of interferon-induced antiviral proteins.
    Haller O; Stertz S; Kochs G
    Microbes Infect; 2007; 9(14-15):1636-43. PubMed ID: 18062906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of sensitivity to interferon in cells infected by murine leukemia-sarcoma viruses.
    Périés J; Canivet M; Olivié M; Sallé M; Boiron M
    J Natl Cancer Inst; 1973 Aug; 51(2):455-63. PubMed ID: 4797258
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of the antiviral action of interferons.
    Samuel CE
    Prog Nucleic Acid Res Mol Biol; 1988; 35():27-72. PubMed ID: 2464840
    [No Abstract]   [Full Text] [Related]  

  • 19. The replication of Rous sarcoma virus is blocked at or before viral DNA synthesis in interferon treated chick embryo fibroblasts.
    Strube W; Jungwirth C
    Eur J Cell Biol; 1985 Nov; 39(1):232-5. PubMed ID: 2417844
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of 2-5 A synthetase activity and antiviral state in interferon treated chick cells.
    Lab M; Thang MN; Soteriadou K; Koehren F; Justesen J
    Biochem Biophys Res Commun; 1982 Mar; 105(2):412-8. PubMed ID: 6178403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.